c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Altered glucose metabolism in cancer cells is termed the Warburg effect, which describes the propensity of most cancer cells to take up glucose avidly and convert it primarily to lactate, despite available oxygen. Notwithstanding the renewed interest in the Warburg effect, cancer cells also depend on continued mitochondrial function for metabolism, specifically glutaminolysis that catabolizes glutamine to generate ATP and lactate. Glutamine, which is highly transported into proliferating cells, is a major source of energy and nitrogen for biosynthesis, and a carbon substrate for anabolic processes in cancer cells, but the regulation of glutamine metabolism is not well understood. Here we report that the c-Myc (hereafter referred to as Myc) oncogenic transcription factor, which is known to regulate microRNAs and stimulate cell proliferation, transcriptionally represses miR-23a and miR-23b, resulting in greater expression of their target protein, mitochondrial glutaminase, in human P-493 B lymphoma cells and PC3 prostate cancer cells. This leads to upregulation of glutamine catabolism. Glutaminase converts glutamine to glutamate, which is further catabolized through the tricarboxylic acid cycle for the production of ATP or serves as substrate for glutathione synthesis. The unique means by which Myc regulates glutaminase uncovers a previously unsuspected link between Myc regulation of miRNAs, glutamine metabolism, and energy and reactive oxygen species homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, checkpoint kinase 1 (CHK1) inhibitors625–627 and glutaminase (GLS) inhibitors628–634 are also considered potential candidates for treating Myc-overexpressing cancers.”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [629]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MYC-driven cancer cells exhibit enhanced glutamine utilization accompanied by increased expression of key glutaminolysis enzymes, including GLS1/GLS2 and GLUD1178–180.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [178]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This was not due to increased protein levels of GLS or c-Myc, which regulates GLS expression”
From Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in Glioma (2018) · cites this paper as Gao et al., 2009
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“genes involved in glutamine metabolism appear to be under both the direct and indirect transcriptional control of the MYC protein (32, 33)”
From Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation (2009) · cites this paper as [33]
The cited source says what the claim attributes to it.
In the citing paper
“It has long been established that Myc activation upregulates glutamine metabolism [79,80], increasing glutamine flux by upregulating the glutamine transporter (ASCT2) and glutaminase-1, thus increasing glutamine conversion to glutamate [81].”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [79]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.040 · Cited by 3,626
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
c-Myc-regulated microRNAs modulate E2F1 expression
O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V., & Mendell, J. T. (2005) · Nature · doi:10.1038/nature03677 · Cited by 2,347
Self-citationTumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337
Widespread microRNA repression by Myc contributes to tumorigenesis
Chang, T.-C., Yu, D., Lee, Y.-S., Wentzel, E. A., Arking, D. E., West, K. M., Dang, C. V., Thomas-Tikhonenko, A., & Mendell, J. T. (2008) · Nature Genetics · doi:10.1038/ng.2007.30 · Cited by 1,325
Self-citationYates, J. R., Eng, J. K., McCormack, A. L., & Schieltz, D. (1995) · Analytical Chemistry · doi:10.1021/ac00104a020 · Cited by 1,253
Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.
Reitzer, L. J., Wice, B. M., & Kennell, D. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30124-2 · Cited by 1,240
Brick by brick: metabolism and tumor cell growth
DeBerardinis, R. J., Sayed, N., Ditsworth, D., & Thompson, C. B. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.02.003 · Cited by 1,018
Eilers, M., & Eisenman, R. N. (2008) · Genes & Development · doi:10.1101/gad.1712408 · Cited by 927
MicroRNA Expression Profiling in Prostate Cancer
Porkka, K. P., Pfeiffer, M. J., Waltering, K. K., Vessella, R. L., Tammela, T. L. J., & Visakorpi, T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0533 · Cited by 899
Cited by
Items 501–600 of 1,006
Zhao, B., Li, H., Liu, J., Han, P., Zhang, C., Bai, H., Yuan, X., Wang, X., Li, L., Ma, H., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015030300 · Cited by 110
Let-7 Suppresses B Cell Activation through Restricting the Availability of Necessary Nutrients
Jiang, S., Yan, W., Wang, S. E., & Baltimore, D. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.12.007 · Cited by 109
Lowman, X. H., Hanse, E. A., Yang, Y., Ishak Gabra, M. B., Tran, T. Q., Li, H., & Kong, M. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.037 · Cited by 102
Lee, S., Jung, J.-W., Park, S.-B., Roh, K., Lee, S. Y., Kim, J. H., Kang, S.-K., & Kang, K.-S. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0457-9 · Cited by 101
Zhang, C., Liu, J., Zhao, Y., Yue, X., Zhu, Y., Wang, X., Wu, H., Blanco, F., Li, S., Bhanot, G., et al. (2016) · eLife · doi:10.7554/elife.10727 · Cited by 101
Are microRNAs true sensors of ageing and cellular senescence?
Williams, J., Smith, F., Kumar, S., Vijayan, M., & Reddy, P. H. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.11.008 · Cited by 101
Metabolic flexibility in melanoma: A potential therapeutic target
Ruocco, M. R., Avagliano, A., Granato, G., Vigliar, E., Masone, S., Montagnani, S., & Arcucci, A. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.016 · Cited by 113
Targeting glutamine metabolism slows soft tissue sarcoma growth
Lee, P., Malik, D. M., Perkons, N. R., Huangyang, P., Khare, S., Rhoades, S. D., Gong, Y.-Y., Burrows, M., Finan, J. M., Nissim, I., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14374-1 · Cited by 109
Mitochondrial Fission and Fusion in Tumor Progression to Metastasis
Boulton, D. P., & Caino, M. C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.849962 · Cited by 114
Myc's other life: stem cells and beyond
Laurenti, E., Wilson, A., & Trumpp, A. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.09.006 · Cited by 119
MicroRNAs, Regulatory Messengers Inside and Outside Cancer Cells
Anfossi, S., Fu, X., Nagvekar, R., & Călin, G. A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-74470-4_6 · Cited by 103
MicroRNAs Dysregulation and Mitochondrial Dysfunction in Neurodegenerative Diseases
Catanesi, M., d’Angelo, M., Tupone, M. G., Benedetti, E., Giordano, A., Castelli, V., & Cimini, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21175986 · Cited by 97
Applications of metabolomics in cancer research
Styczynski, M. P., & Vermeersch, K. A. (2013) · Journal of Carcinogenesis · doi:10.4103/1477-3163.113622 · Cited by 118
Sun, T., Yang, M., Chen, S., Balk, S. P., Pomerantz, M. M., Hsieh, C.-L., Brown, M. A., Lee, G. M., & Kantoff, P. W. (2011) · The Prostate · doi:10.1002/pros.22456 · Cited by 106
Interplay of mitochondrial metabolism and microRNAs
Geiger, J., & Dalgaard, L. T. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2342-7 · Cited by 112
microRNA-23a in Human Cancer: Its Roles, Mechanisms and Therapeutic Relevance
Wang, N., Tan, H.-Y., Feng, Y.-G., Zhang, C., Chen, F., & Feng, Y. (2018) · Cancers · doi:10.3390/cancers11010007 · Cited by 99
Vallée, A., Lecarpentier, Y., & Vallée, J.-N. (2021) · Cancers · doi:10.3390/cancers13215557 · Cited by 109
Xiang, Y., Cheng, J., Wang, D., Hu, X., Xie, Y., Stitham, J., Atteya, G. A., Du, J., Tang, W. H., Lee, S. H., et al. (2015) · Blood · doi:10.1182/blood-2015-01-620278 · Cited by 111
Xu, X., Li, J., Sun, X. Y., Guo, Y. H., Chu, D., Wei, L., Li, X., Yang, G., Liu, X., Yao, L., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4544 · Cited by 99
Glutaminase isoenzymes in the metabolic therapy of cancer
Matés, J. M., Campos-Sandoval, J. A., & Márquez, J. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.07.007 · Cited by 98
Forte, E., Salinas, R. E., Chang, C., Zhou, T., Linnstaedt, S. D., Gottwein, E., Jacobs, C., Jima, D., Li, Q.-J., Dave, S. S., et al. (2012) · Journal of Virology · doi:10.1128/jvi.07056-11 · Cited by 97
Tang, X., Keenan, M. M., Wu, J., Lin, C.-A., Dubois, L. G., Thompson, J. W., Freedland, S. J., Murphy, S. K., & Chi, J. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005158 · Cited by 111
Long non-coding RNAs involved in cancer metabolic reprogramming
Liu, H., Luo, J., Luan, S., He, C., & Li, Z. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2946-1 · Cited by 100
Saha, S. K., Islam, S. M. R., Abdullah-Al-Wadud, M., Islam, M. S., Ali, F., & Park, K. S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8030355 · Cited by 102
Aguilar, E., Marin de Mas, I., Zodda, E., Marin, S., Morrish, F., Selivanov, V., Meca-Cortés, Ó., Delowar, H., Pons, M., Izquierdo, I., et al. (2016) · Stem Cells · doi:10.1002/stem.2286 · Cited by 96
A c-Myc-MicroRNA functional feedback loop affects hepatocarcinogenesis
Han, H., Sun, D., Li, W., Shen, H., Zhu, Y., Li, C., Chen, Y., Lu, L., Li, W., Zhang, J., et al. (2013) · Hepatology · doi:10.1002/hep.26302 · Cited by 96
Metabolic Plasticity of Tumor Cell Mitochondria
Cannino, G., Ciscato, F., Masgras, I., Sànchez‐Martìn, C., & Rasola, A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00333 · Cited by 103
Glutamine Metabolism in Brain Tumors
Natarajan, S. K., & Venneti, S. (2019) · Cancers · doi:10.3390/cancers11111628 · Cited by 103
Defining a metabolic landscape of tumours: genome meets metabolism
Nanda, C. S., Venkateswaran, S. V., Patani, N., & Yuneva, M. O. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0663-7 · Cited by 106
Harding, J. J., Telli, M. L., Münster, P. N., Voss, M. H., Infante, J. R., DeMichele, A. M., Dunphy, M. P., Le, M. H., Molineaux, C., Orford, K. W., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1204 · Cited by 112
Regulation of rDNA transcription in response to growth factors, nutrients and energy
Kusnadi, E. P., Hannan, K. M., Hicks, R. J., Hannan, R. D., Pearson, R. B., & Kang, J. (2014) · Gene · doi:10.1016/j.gene.2014.11.010 · Cited by 117
miR‐290/371‐Mbd2‐Myc circuit regulates glycolytic metabolism to promote pluripotency
Cao, Y., Guo, W., Tian, S., He, X., Wang, X., Liu, X., Gu, K., Ma, X., Huang, D., Hu, L., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201490441 · Cited by 100
Self-citationZeng, H.-C., Bae, Y., Dawson, B. C., Chen, Y., Bertin, T., Munivez, E., Campeau, P. M., Tao, J., Chen, R., & Lee, B. H. (2017) · Nature Communications · doi:10.1038/ncomms15000 · Cited by 95
Altered glutamine metabolism in breast cancer; subtype dependencies and alternative adaptations
Ansari, R. E., McIntyre, A., Craze, M. L., Ellis, I. O., Rakha, E. A., & Green, A. R. (2017) · Histopathology · doi:10.1111/his.13334 · Cited by 99
Modulation of dysregulated cancer metabolism by plant secondary metabolites: A mechanistic review
Fakhri, S., Moradi, S. Z., Farzaei, M. H., & Bishayee, A. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.02.007 · Cited by 107
MicroRNA signatures in B-cell lymphomas
Lisio, L. D., Sánchez‐Beato, M., Goméz-López, G., Rodríguez, M. E., Montes‐Moreno, S., Mollejo, M., Menárguez, J., Martínez, M. Á. M., Alves, F. J., Pisano, D. G., et al. (2012) · Blood Cancer Journal · doi:10.1038/bcj.2012.1 · Cited by 104
Lee, P., Vousden, K. H., & Cheung, E. C. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-1 · Cited by 107
Altered glutamine metabolism in platinum resistant ovarian cancer
Hudson, C. D., Savadelis, A., Nagaraj, A. B., Joseph, P. L., Avril, S., DiFeo, A. V., & Avril, N. E. (2016) · Oncotarget · doi:10.18632/oncotarget.9317 · Cited by 102
Wu, X., Ajani, J. A., Gu, J. H., Chang, D. W., Tan, W., Hildebrandt, M. A. T., Huang, M., Wang, K. K., & Hawk, E. T. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0276 · Cited by 98
MicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insights
Dettmer, M. S., Perren, A. A., Moch, H., Komminoth, P., Nikiforov, Y. E., & Nikiforova, M. N. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0266 · Cited by 98
MYC regulation of glutamine–proline regulatory axis is key in luminal B breast cancer
Craze, M. L., Cheung, H., Jewa, N., Coimbra, N. D. M., Soria, D., Ansari, R. E., Aleskandarany, M. A., Cheng, K. W., Diez, M., Nolan, C. C., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.387 · Cited by 100
NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML
Sasca, D., Szybinski, J., Schüler, A., Shah, V., Heidelberger, J. B., Haehnel, P. S., Dolnik, A., Kriege, O., Fehr, E.-M., Gebhardt, W. H., et al. (2019) · Blood · doi:10.1182/blood-2018-12-889725 · Cited by 113
Mitochondrial noncoding RNA-regulatory network in cardiovascular disease
(CA17129), T. E.-C. C. A., Jusić, A., & Devaux, Y. (2020) · Basic Research in Cardiology · doi:10.1007/s00395-020-0783-5 · Cited by 106
Comparative Evaluation of 18F-Labeled Glutamic Acid and Glutamine as Tumor Metabolic Imaging Agents
Ploessl, K., Wang, L., Lieberman, B. P., Qu, W., & Kung, H. F. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.101279 · Cited by 94
Glutamine Transporters Are Targets of Multiple Oncogenic Signaling Pathways in Prostate Cancer
White, M. A., Lin, C., Rajapakshe, K., Dong, J., Shi, Y., Tsouko, E., Mukhopadhyay, R., Jasso, D., Dawood, W., Coarfa, C., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0480 · Cited by 99
Phosphoinositide 3-kinase inhibitors induce DNA damage through nucleoside depletion
Juvekar, A., Hu, H., Yadegarynia, S., Lyssiotis, C. A., Ullas, S., Lien, E. C., Bellinger, G., Son, J., Hok, R. C., Seth, P., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522223113 · Cited by 93
“Candidate mechanisms that could explain a metabolic bypass that allows for resurgent DNA synthesis while glucose uptake remains suppressed with ongoing PI3K inhibition potentially may include the following: (i) acquired myc amplification, which has been observed in PI3K inhibitor-resistant breast cancer cells (37, 38)…”
BackgroundWang, N., Zhu, M., Wang, X., Tan, H.-Y., Tsao, S.-W., & Feng, Y. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.05.027 · Cited by 93
Dimri, M., Humphries, A., Laknaur, A., Elattar, S., Lee, T. J., Sharma, A. K., Kolhe, R. B., & Ande, S. (2019) · Hepatology · doi:10.1002/hep.30818 · Cited by 99
Wang, R., Cao, L., Thorne, R. F., Zhang, X. D., Li, J., Shao, F., Zhang, L., & Wu, M. (2021) · Science Advances · doi:10.1126/sciadv.abe5708 · Cited by 101
Zhu, Y., Li, T., Ramos da Silva, S., Lee, J.-J., Lu, C., Eoh, H., Jung, J. U., & Gao, S.-J. (2017) · mBio · doi:10.1128/mbio.01179-17 · Cited by 91
Koch, K., Hartmann, R., Tsiampali, J., Uhlmann, C., Nickel, A., He, X., Kamp, M. A., Sabel, M., Barker, R. A., Steiger, H., et al. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-0258-3 · Cited by 91
Isotopically nonstationary 13C flux analysis of Myc-induced metabolic reprogramming in B-cells
Murphy, T. A., Dang, C. V., & Young, J. D. (2013) · Metabolic Engineering · doi:10.1016/j.ymben.2012.07.008 · Cited by 91
Self-citationGlutaminases regulate glutathione and oxidative stress in cancer
Matés, J. M., Campos-Sandoval, J. A., de los Santos-Jiménez, J., & Márquez, J. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02838-8 · Cited by 91
Shen, Y., Hong, J., Asaka, R., Asaka, S., Hsu, F., Rahmanto, Y. S., Jung, J.-G., Chen, Y.-W., Yen, T., Tomaszewski, A., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3971 · Cited by 95
Metabolic plasticity drives development during mammalian embryogenesis
Sharpley, M. S., Chi, F., ten Hoeve, J., & Banerjee, U. K. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.07.020 · Cited by 102
Ferreira, A. P. S., Cassago, A., Gonçalves, K. D. A., Dias, M. M., Adamoski, D., Ascenção, C. F. R., Honorato, R. V., de Oliveira, J. F., Ferreira, I. M., Fornezari, C., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.501346 · Cited by 89
Ishteiwy, R., Ward, T. M., Dykxhoorn, D. M., & Burnstein, K. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052106 · Cited by 94
Molecular Crosstalk Between MYC and HIF in Cancer
Li, Y., Sun, X.-X., Qian, D. Z., & Dai, M.-S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.590576 · Cited by 89
Metabolic dependencies and vulnerabilities in leukemia
Rashkovan, M., & Ferrando, A. A. (2019) · Genes & Development · doi:10.1101/gad.326470.119 · Cited by 100
MicroRNAs in Tumor Cell Metabolism: Roles and Therapeutic Opportunities
Pedroza‐Torres, A., Romero-Cordoba, S. L., Justo-Garrido, M., Salido-Guadarrama, I., Rodríguez‐Bautista, R., Montaño, S., Muñiz-Mendoza, R., Arriaga-Canon, C., Fragoso‐Ontiveros, V., Álvarez-Gómez, R. M., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01404 · Cited by 97
Glutaminase in microglia: A novel regulator of neuroinflammation
Ding, L., Xu, X., Li, C., Wang, Y., Xia, X., & Zheng, J. C. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.11.038 · Cited by 88
Advancing Cancer Treatment by Targeting Glutamine Metabolism—A Roadmap
Halama, A., & Suhre, K. (2022) · Cancers · doi:10.3390/cancers14030553 · Cited by 104
Martín-Rufián, M., Nascimento-Gomes, R., Higuero, A., Crisma, A. R., Campos-Sandoval, J. A., Gómez-García, M. C., Cardona, C., Cheng, T., Lobo, C., Segura, J. A., et al. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1105-2 · Cited by 88
MicroRNAs, Aging, Cellular Senescence, and Alzheimer's Disease
Reddy, P. H., Williams, J. M., Smith, F., Bhatti, J. S., Kumar, S., Vijayan, M., Kandimalla, R. J. L., Kuruva, C. S., Wang, R., Mańczak, M., et al. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.009 · Cited by 102
Expression of glutaminase is upregulated in colorectal cancer and of clinical significance.
(2014) · Europe PMC (PubMed Central) · Cited by 89
Molecular Pathways: Metabolic Control of Histone Methylation and Gene Expression in Cancer
Tran, T. Q., Lowman, X. H., & Kong, M. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2506 · Cited by 103
PGK1 Drives Hepatocellular Carcinoma Metastasis by Enhancing Metabolic Process
Xie, H., Tong, G., Zhang, Y., Liang, S., Tang, K., & Yang, Q. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081630 · Cited by 87
Jiang, H., Zhang, N., Tang, T., Feng, F., Sun, H., & Qu, W. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104844 · Cited by 97
Bouhamida, E., Morciano, G., Perrone, M., Kahsay, A. E., Della Sala, M., Wieckowski, M. R., Fiorica, F., Pinton, P., Giorgi, C., & Patergnani, S. (2022) · Biology · doi:10.3390/biology11020300 · Cited by 87
Qie, S., Chu, C., Li, W., Wang, C., & Sang, N. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24684 · Cited by 87
Wu, D., Zhuo, L., & Wang, X. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.11.003 · Cited by 92
Cystine addiction of triple-negative breast cancer associated with EMT augmented death signaling
Tang, X., Ding, C.-K., Wu, J., Sjol, J., Wardell, S. E., Spasojević, I., George, D. J., McDonnell, D. P., Hsu, D. S., Chang, J. T., et al. (2016) · Oncogene · doi:10.1038/onc.2016.394 · Cited by 87
Systemic effects of mitochondrial stress
Bar‐Ziv, R., Bolas, T., & Dillin, A. G. (2020) · EMBO Reports · doi:10.15252/embr.202050094 · Cited by 89
Targeting GLS1 to cancer therapy through glutamine metabolism
Yu, W., Yang, X., Zhang, Q., Sun, L., Yuan, S., & Xin, Y. (2021) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02645-2 · Cited by 92
Rho GTPases and their roles in cancer metabolism
Wilson, K. F., Erickson, J. W., Antonyak, M. A., & Cerione, R. A. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.10.011 · Cited by 86
The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogramming
Phan, L. M., Chou, P., Velázquez-Torres, G., Samudio, I. J., Parreno, K., Huang, Y., Tseng, C., Vu, T., Gully, C., Su, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms8530 · Cited by 91
Immunometabolism in cancer at a glance
Singer, K., Cheng, W.-C., Kreutz, M. P., Ho, P., & Siska, P. J. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.034272 · Cited by 92
High-resolution metabolomic biomarkers for lung cancer diagnosis and prognosis
Qi, S.-A., Wu, Q., Chen, Z., Zhang, W., Zhou, Y., Mao, K., Li, J., Li, Y., Chen, J., Huang, Y., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-91276-2 · Cited by 93
Non-glucose metabolism in cancer cells—is it all in the fat?
Biswas, S., Lunec, J., & Bartlett, K. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9384-6 · Cited by 91
Nitrogen anabolism underlies the importance of glutaminolysis in proliferating cells
Meng, M., Chen, S., Lao, T., Liang, D., & Sang, N. (2010) · Cell Cycle · doi:10.4161/cc.9.19.13139 · Cited by 86
Nilsson, L. M., Plym Forshell, T. Z., Rimpi, S., Kreutzer, C., Pretsch, W., Bornkamm, G. W., & Nilsson, J. A. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002573 · Cited by 85
“Furthermore, Myc-regulated Ldha, Pyruvate kinase M2 and Glutaminase have also emerged as promising targets based on experimental models of human cancer [16–23], suggesting that targeting various metabolic pathways regulated by Myc may prove beneficial in cancer therapies of patients.”
BackgroundSandoval, J., Díaz‐Lagares, Á., Salgado, R., Servitje, O., Climent, F., Ortiz-Romero, P. L., Pérez‐Ferriols, A., García-Muret, M. P., Estrach, T., Garcia, M., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.487 · Cited by 85
Gao, G., Zhao, S., Xia, X., Li, C., Li, C., Ji, C., Sheng, S., Tang, Y., Zhu, J., Wang, Y., et al. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00264 · Cited by 85
Shajahan‐Haq, A. N., Cook, K. L., Schwartz‐Roberts, J. L., Eltayeb, A. E., Demas, D. M., Wärri, A. M., Facey, C. O. B., Hilakivi-Clarke, L. A., & Clarke, R. C. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-239 · Cited by 94
Cystine Deprivation Triggers Programmed Necrosis in VHL-Deficient Renal Cell Carcinomas
Tang, X., Wu, J., Ding, C. C., Lu, M., Keenan, M. M., Lin, C., Lin, C.-A., Wang, C. C., George, D. J., Hsu, D. S., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2328 · Cited by 88
Dlx-2 and glutaminase upregulate epithelial-mesenchymal transition and glycolytic switch
Lee, S. Y., Jeon, H. M., Ju, M. K., Jeong, E. K., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2016) · Oncotarget · doi:10.18632/oncotarget.6879 · Cited by 85
Myc/miR-378/TOB2/cyclin D1 functional module regulates oncogenic transformation
Feng, M., Li, Z., Aau, M., Wong, C., Yang, X., & Yu, Q. (2011) · Oncogene · doi:10.1038/onc.2010.602 · Cited by 94
Oncogene-Driven Metabolic Alterations in Cancer
Min, H., & Lee, H. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.211 · Cited by 92
Sirtuins and the Metabolic Hurdles in Cancer
German, N. J., & Haigis, M. C. (2015) · Current Biology · doi:10.1016/j.cub.2015.05.012 · Cited by 83
Autophagy is required for PDAC glutamine metabolism
Seo, J.-W., Choi, J., Lee, S.-Y., Sung, S., Yoo, H. J., Kang, M.-J., Cheong, H., & Son, J. (2016) · Scientific Reports · doi:10.1038/srep37594 · Cited by 84
MYC and HIF in shaping immune response and immune metabolism
Gnanaprakasam, J. R., Sherman, J. W., & Wang, R. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.03.004 · Cited by 86
Hallmarks of Metabolic Reprogramming and Their Role in Viral Pathogenesis
Allen, C. N. S., Arjona, S. P., Santerre, M., & Sawaya, B. E. (2022) · Viruses · doi:10.3390/v14030602 · Cited by 86
Amino acid metabolism reprogramming: shedding new light on T cell anti-tumor immunity
Zheng, Y., Yao, Y., Ge, T., Ge, S., Jia, R., Song, X., & Zhuang, A. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02845-4 · Cited by 102
Sun, X., Zhang, J., Hou, Z., Han, Q., Zhang, C., & Tian, Z. (2015) · Cell Cycle · doi:10.4161/15384101.2014.977112 · Cited by 92
B-Cell Metabolic Remodeling and Cancer
Franchina, D. G., Grusdat, M., & Brenner, D. (2018) · Trends in cancer · doi:10.1016/j.trecan.2017.12.006 · Cited by 89
The Dual Roles of the Atypical Protein Kinase Cs in Cancer
Reina‐Campos, M., Díaz-Meco, M. T., & Moscat, J. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.07.010 · Cited by 92
Sirt4: A Multifaceted Enzyme at the Crossroads of Mitochondrial Metabolism and Cancer
Tomaselli, D., Steegborn, C., Mai, A., & Rotili, D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00474 · Cited by 81
Emerging Metabolic Targets in Cancer Therapy
Zhao, Y., Liu, H., Riker, A. I., Fodstad, Ø., LeDoux, S. P., Wilson, G. L., & Tan, M. (2010) · Frontiers in bioscience · doi:10.2741/3826 · Cited by 90
The role of microRNAs in mitochondria in cancer
Vašků, J. B., Šáňa, J., & Slabý, O. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.05.001 · Cited by 89
Chen, Z., Wang, Y., Warden, C., & Chen, S. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.02.004 · Cited by 82
Metadata
- Authors
- Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., & Dang, C. V.
- Affiliations
- Johns Hopkins University (US)
- Teikyo University (JP)
- Corresponding author
- Gao, Ping
- Dang, Chi V.
- Venue
- Nature
- Published
- 2009-02-15
- Volume
- 458
- Issue
- 7239
- Pages
- 762-765
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2729443
- OpenAlex
- W2074873270
- Cited by
- 2,124
- References
- 30
- Citations by year
- 2026: 50 · 2025: 85 · 2024: 105 · 2023: 138 · 2022: 131 · 2021: 142 · 2020: 158 · 2019: 146 · 2018: 146 · 2017: 134 · 2016: 126 · 2015: 145 · 2014: 161 · 2013: 125 · 2012: 144
- FWCI
- 37.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Funders
- National Institutes of Health (n01hv28180-13-0-0)
- National Heart, Lung, and Blood Institute (N01 HV-28180, N01 HV028180, R01HL085434)
- National Cancer Institute (R01 CA57341, R01CA057341, R01CA120185, P50CA058236, R37CA051497, P50-CA58236, R01CA051497)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- c-Myc, miR-23a, miR-23b, glutamine metabolism, glutaminolysis, microRNA regulation, cancer metabolism, Warburg effect, PC-3 cells, reactive oxygen species, glutathione synthesis
- MeSH terms
- Glutaminase, Glutamine, Humans, Mitochondria, Gene Expression Regulation, Enzymologic, Proto-Oncogene Proteins c-myc, 3' Untranslated Regions, MicroRNAs, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.